Dieticians are warning that GLP-1 use can lead to extreme malnutrition, manifesting in diseases like scurvy, amid findings that the vast majority of studies fail to consider patients’ eating habits.

Discontinuing GLP-1 treatment does not always cause significant weight gain, as many patients transition to other obesity or diabetes treatments, according to a Cleveland Clinic study published March ...

“RESIST SAYING, ‘this will be no panacea’. When you find something that is a panacea, that will indeed be news.” This wise advice once appeared in The Economist’s Style Guide, and the first part is ...

Cyndy Dowling struggled with her weight for decades until she found what she thought was a lifelong solution: a monthly injection of one of the popular new weight-loss drugs. The 69-year-old easily ...

Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...

Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities. Reading time 3 minutes Trying to get a bargain ...

The rise of GLP-1s for weight loss has been swift and sudden. Not long ago, the drugs were mainly used by diabetes sufferers. Today, they’re synonymous for many with weight loss, leading consumers to ...

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...

Pancreatic enzyme replacement therapy (PERT) — commonly used to reverse the insufficient secretion of pancreatic enzymes, or pancreatic exocrine insufficiency (PEI) — showed benefit in the treatment ...

Every bite matters when you start taking a GLP-1. Prioritizing nutrient-dense foods that support your gut and digestive health and maintaining proper hydration can make a real difference in your ...

Ascletis Pharma has posted phase 2 data on its ultra-long-acting GLP-1 receptor analog, generating early evidence that the formulation may support quarterly dosing as a maintenance therapy. Eli ...

There’s been chatter on social media for years about potential side effects you can experience from taking GLP-1 medications, whether it’s "Ozempic face" or "Ozempic butt". But the latest side effect ...